MSM for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

MSM for Health & Longevity

Created on 10/15/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

MSM, an inexpensive sulfur-containing dietary supplement also made by the body, is used mainly for joint comfort. Its best-supported use, easing knee arthritis pain and improving function, shows a modest, uncertain short-term benefit. Exercise, allergy, skin, hair and cancer claims rest on small, uncontrolled or animal studies. Side effects were mild in trials, with one eye-pressure emergency reported; long-term use is unstudied, and nothing ties MSM to longer life. (Full Review)

Protocol

Osteoarthritis dosing
1.5–6 g/day
Trials split it into two or three doses, from 500 mg three times daily to 3 g twice daily
General and active-adult dosing
3 g/day
Used in exercise and metabolic trials; 2 g/day for mild knee pain
Time of day
With breakfast and an early evening meal
Common practice; no study compared timing
Time to effect
Knee pain and function
4–12 weeks
Osteoarthritis trials measured differences at 4–12 weeks
Facial skin aging signs
16 weeks
Fewer facial wrinkles at 3 g/day in a 20-person pilot
Seasonal allergy symptoms
Within 7 days
Improved in an uncontrolled study

Benefits

Contraindications
  • Prior acute angle-closure glaucoma or known narrow eye-drainage angles (theoretical)
  • Pregnancy or breastfeeding (human safety data lacking)
  • Known hypersensitivity to MSM
  • Advanced chronic kidney disease (theoretical)
    •
Key Interactions
  • Prescription anticoagulants and antiplatelets (blood thinners: warfarin, apixaban, clopidogrel): monitor (theoretical)
  • Drugs that can trigger angle closure (topiramate, acetazolamide, anticholinergics such as diphenhydramine): caution (theoretical)
  • Topical DMSO (dimethyl sulfoxide): caution (theoretical)
  • Cannabidiol (CBD)-rich extracts: monitor (theoretical in humans)
  • Glucosamine and chondroitin: additive (intended)
  • Drugs cleared by CYP (liver drug-processing) enzymes (warfarin, atorvastatin, omeprazole): no interaction expected (laboratory data)
  • NSAIDs (nonsteroidal anti-inflammatory drugs such as naproxen, ibuprofen): no interaction found
  • Curcumin, boswellia and pine bark extracts: no interaction found
  • Resistance and endurance training: no interaction shown
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Mild gastrointestinal upset and minor complaints; Acute angle-closure glaucoma
    •
  • Speculative: Long-term brain accumulation; Reproductive toxicity
    •

Monitoring

Marker Target Why
Serum creatinine / eGFR Creatinine about 0.7–1.3 mg/dL (men), 0.6–1.1 mg/dL (women); eGFR 60 mL/min/1.73 m² or higher Safety check: MSM is cleared in urine
ALT About 7–55 U/L Safety check, especially with other supplements
hs-CRP No established target; change from the individual's own baseline Marker MSM is proposed to change (human data inconclusive)

Cadence: Baseline before starting; symptom scores at 4 and 12 weeks, then every 6 months; creatinine, eGFR and ALT at 12 weeks for doses of 3 g/day or more, then every 12 months; hs-CRP at 12 weeks only if measured at baseline

Qualitative Assessment

  • Joint pain during daily activities and after exercise
  • Morning stiffness duration
  • Ease of stairs, walking distance and getting up from a chair
  • Post-workout muscle soreness and recovery time
  • Seasonal nasal symptoms, if allergy relief is a goal
  • Gastrointestinal comfort and any new eye symptoms
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.